Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia
Ocaratuzumab 是一种 Fc 工程抗体，在慢性淋巴细胞白血病中表现出增强的抗体依赖性细胞介导的细胞毒性
期刊:MAbs
影响因子:5.6
doi:10.4161/mabs.28282
Carolyn M Cheney, Deborah M Stephens, Xiaokui Mo, Sarwish Rafiq, Jonathan Butchar, Joseph M Flynn, Jeffrey A Jones, Kami Maddocks, Adrienne O'Reilly, Abhijit Ramachandran, Susheela Tridandapani, Natarajan Muthusamy, John C Byrd
